Top 25 EPCIS Data Errors That Break Interoperability (and How to Prevent Them)

Interoperability is the central promise of DSCSA’s enhanced drug distribution security requirements. Every trading partner in the U.S. pharmaceutical supply chain is expected to exchange serialized product data in a standardized, electronically readable format that compliant systems can receive, validate, and act on. EPCIS is the vehicle for that exchange.

In practice, interoperability breaks constantly. Not because systems are disconnected, but because the data flowing between connected systems is wrong. Missing fields, invalid identifiers, mismatched event types, incorrect timestamps, and schema non-conformance all create friction points that delay product movement, trigger investigations, or corrupt downstream traceability records. The GS1 US DSCSA Implementation Guideline Release 1.3, the GS1 EPCIS standard, and FDA’s guidance on interoperable package-level tracing all point to the same operational truth: data quality is what makes or breaks the network. FDA package-level guidance

This post turns that reality into a practical reference, organizing the most common EPCIS data errors interoperability issues into five categories and pairing each with a prevention control that helps stop the error before it reaches a trading partner.

Why EPCIS interoperability fails in the real world

Most teams assume interoperability failure means two systems are not connected. Usually, the systems are connected. The real problem is that the data exchanged across that connection is incomplete, inconsistent, or technically valid but operationally unusable. That is why strong interoperability requires more than transport. It requires identifier discipline, event-structure discipline, choreography discipline, and governance discipline.

Category 1: Identifier errors

Identifier issues are among the most common causes of EPCIS validation errors DSCSA environments encounter. These failures happen when identifiers in the EPCIS event do not match the product, master data, or the receiving system’s formatting expectations.

Many of these are avoidable master-data failures. If identifiers are not governed before shipment, they become exception-handling work after shipment. That is exactly why a stronger data foundation matters so much in serialization programs.

Category 2: Event structure errors

These are classic EPCIS schema errors pharma teams run into when the event itself is malformed, incomplete, or uses the wrong semantics. A file can be syntactically close to valid and still break the receiving process if required event logic is missing.

Category 3: Transmission and connectivity errors

Transmission issues are often treated as pure IT incidents, but in DSCSA operations they quickly become product-flow problems. These errors block exchange, delay acknowledgment, and create ambiguity about whether product data has actually been received.

These issues are especially dangerous because they can look like silent success unless MDN tracking, retry logic, and visibility dashboards are already in place.

Category 4: Business process and choreography errors

Some of the most frustrating EPCIS event errors serialization teams face are not schema failures at all. They are choreography failures. The event data may be technically valid, but it is generated in the wrong sequence, at the wrong point in the business flow, or without the context the trading partner expects. GS1 R1.3 and its choreographies make this very clear.

These failures are easy to miss because the file may pass technical checks while still breaking interoperability at the business-process level.

Category 5: Data governance and master data errors

The final group sits at the governance layer. These are the errors that keep returning if the organization treats EPCIS as a messaging project instead of a data discipline.

A prevention framework that catches errors before transmission

Individual controls matter, but the highest-leverage improvement is a systematic validation layer that runs before every transmission. Four controls catch the majority of the issues above:

• Pre-transmission schema validation: validate every file against the applicable GS1 schema before sending
• Identifier cross-validation: cross-check GTIN, lot, expiry, and serial numbers against current ERP batch records
• Partner onboarding data agreement: document GLNs, EPCIS version, protocol, file-size limits, and choreography expectations before first exchange
• Post-transmission MDN monitoring: treat missing acknowledgment as a transmission failure and route it into the exception workflow

For the broader operational context around migration and ongoing execution, this topic also connects naturally to SCW’s EPCIS 2.0 thought leadership and to the DSCSA exception handling playbook that should govern what happens when these errors still make it through.

Final thought

EPCIS data quality pharma supply chain work is not a one-time implementation task. It is an ongoing operational discipline. The 25 errors above are not theoretical. They are the patterns that keep appearing in production environments, often repeatedly and often from the same underlying weaknesses. The organizations that achieve durable interoperability are the ones that catch those weaknesses at the source, in event configuration, master-data governance, onboarding, and monitoring, rather than discovering them through partner complaints or blocked shipments.